U.S. Physical Therapy, Inc. $USPH Shares Acquired by American Century Companies Inc.

Key Points

• American Century Companies Inc. increased its holdings in U.S. Physical Therapy by 45.9% in the first quarter, owning about 0.09% of the company worth $955,000.
• U.S. Physical Therapy reported a 0.81 EPS for the quarter, exceeding analysts' estimates and showcasing a 18.0% year-over-year revenue growth.
• The company announced a quarterly dividend of $0.45 per share, indicating an annual yield of 2.2% with a payout ratio of 78.60%.

American Century Companies Inc. lifted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 45.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,204 shares of the company's stock after acquiring an additional 4,153 shares during the period. American Century Companies Inc. owned 0.09% of U.S. Physical Therapy worth $955,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Portside Wealth Group LLC lifted its position in shares of U.S. Physical Therapy by 3.9% during the 1st quarter. Portside Wealth Group LLC now owns 4,108 shares of the company's stock worth $297,000 after buying an additional 154 shares during the last quarter. Precision Wealth Strategies LLC lifted its position in shares of U.S. Physical Therapy by 6.6% during the 1st quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company's stock worth $221,000 after buying an additional 189 shares during the last quarter. Bessemer Group Inc. lifted its position in shares of U.S. Physical Therapy by 4.4% during the 1st quarter. Bessemer Group Inc. now owns 4,929 shares of the company's stock worth $357,000 after buying an additional 208 shares during the last quarter. Albert D Mason Inc. lifted its position in shares of U.S. Physical Therapy by 2.5% during the 1st quarter. Albert D Mason Inc. now owns 10,856 shares of the company's stock worth $786,000 after buying an additional 260 shares during the last quarter. Finally, Fifth Third Bancorp lifted its position in shares of U.S. Physical Therapy by 34.6% during the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock worth $75,000 after buying an additional 265 shares during the last quarter.

Insider Activity

In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the business's stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the transaction, the director directly owned 2,594 shares of the company's stock, valued at approximately $202,357.94. The trade was a 13.36% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Graham D. Reeve sold 1,792 shares of the business's stock in a transaction on Monday, August 11th. The shares were sold at an average price of $86.57, for a total transaction of $155,133.44. Following the completion of the transaction, the chief operating officer directly owned 22,246 shares in the company, valued at $1,925,836.22. This represents a 7.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,653 shares of company stock valued at $478,334. 2.00% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have recently weighed in on USPH shares. Zacks Research upgraded shares of U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. Barrington Research boosted their price objective on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock traded down $0.22 during trading on Friday, reaching $85.60. The company's stock had a trading volume of 134,439 shares, compared to its average volume of 139,210. The company has a 50-day moving average price of $79.79 and a two-hundred day moving average price of $76.63. The firm has a market cap of $1.30 billion, a PE ratio of 37.38, a P/E/G ratio of 4.29 and a beta of 1.47. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $101.19. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The business had revenue of $197.34 million for the quarter, compared to analysts' expectations of $190.24 million. During the same period in the previous year, the company posted $0.73 EPS. The company's quarterly revenue was up 18.0% on a year-over-year basis. On average, analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 22nd will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 22nd. U.S. Physical Therapy's payout ratio is currently 78.60%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.